Ortho Clinical Diagnostics has launched a new COVID-19 antibody test VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test, following the US Food and Drug Administration (FDA) Emergency Use...
Vela Diagnostics has secured CE mark approval for the manual version of the ViroKey SARS-CoV-2 RT-PCR test for in vitro diagnostic applications. The test will help...
US-based digital biology company Recursion has unveiled its open-source RxRx19 dataset, which is the first human cellular morphological dataset of SARS-CoV-2, which causes COVID-19. The company...
ALung Technologies has secured emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Hemolung respiratory assist system (RAS) to treat patients...
In an effort to make medical imaging more available to COVID-19 patients, the U.S. Food and Drug Administration (FDA) is relaxing its rules on modification of...
Vela Diagnosticsannounced today that the manual version of the ViroKey™ SARS-CoV-2 RT-PCR Test has received the CE mark for in vitro diagnostic use. The test detects SARS-CoV-2 in...
The Plasma Protein Therapeutics Association (PPTA) applauds the Administration for comments made during the April 23 White House Coronavirus Task Force briefing in which Americans were encouraged to contact their...
One of the possible treatments being investigated for COVID-19 is the use of convalescent antibodies. That is to say, finding patients who recovered from the disease,...
ProThera Biologics and Takeda Pharmaceutical announced on Friday that they had entered a global licensing agreement to develop a novel plasma-derived Inter-alpha Inhibitor Proteins (IAIP) therapy. The goal is to...
Less than one month after Johnson & Johnson identified a lead vaccine candidate against COVID-19, the life sciences giant announced an agreement with Emergent BioSolutions to support the manufacturing needs for...
By now, I’m sure you know the breakneck pace researchers are moving to find drugs and develop a vaccine against SARS-CoV-2, the novel coronavirus that causes...
AstraZeneca and Merck released more positive data from the Phase III PROfound trial of Lynparza (olaparib) in metastatic castration-resistant prostate cancer (mCRPC). Specifically, in patients who have a homologous recombination...
The U.S. Food and Drug Administration (FDA) has greenlit Sanofi’s MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive meningococcal disease in individuals at least two years old, the company announced...
Melbourne, Australia and New York-based Mesoblast Limited announced that in a study of COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS), there was 83% survival with two intravenous...
U.S. President Donald Trump’s musings on whether injecting disinfectants might treat COVID-19 horrified medical professionals on Friday and raised fresh concerns that his stream-of-consciousness briefings could...
Copyright © 2024 Medical Buyer